Kleefstra syndrome due to a point mutation is a rare genetic condition that usually affects development from infancy or early childhood. Common features include low muscle tone, developmental delay, learning disability, and delayed or limited speech, and some people also have seizures, sleep problems, or heart defects. Not everyone will have the same experience. Kleefstra syndrome due to a point mutation is lifelong, and treatment focuses on support such as speech, physical, and occupational therapy, along with care for issues like feeding, behavior, or seizures. Life expectancy can vary, but many people with Kleefstra syndrome live into adulthood, especially when major medical problems are recognized and treated early.
How many people live with Kleefstra syndrome due to a point mutation?
Using Orphanet's estimate that Kleefstra syndrome overall affects fewer than 1 in 1,000,000 people, that would mean fewer than about 8,100 people worldwide and fewer than about 340 people in the United States (Orphanet, 2024). Published case series suggest that small EHMT1 gene changes, often called point mutations, make up roughly 25% to 50% of diagnosed Kleefstra syndrome cases, so this form may account for fewer than about 2,000 to 4,000 people worldwide and fewer than about 85 to 170 people in the U.S.; these are rough estimates rather than direct counts (GeneReviews, 2019; Orphanet, 2024).
Overview
Kleefstra syndrome due to a point mutationSymptoms
Kleefstra syndrome due to a point mutation often affects development from infancy. Common features include low muscle tone, delayed speech and learning, and distinctive facial features. Some children also have seizures, sleep problems, or heart defects.
Outlook and prognosis
Kleefstra syndrome due to a point mutation is lifelong, but outlook varies. Many children need ongoing support for learning, speech, and daily skills. With early therapies and regular care, many make steady progress and can enjoy strong family connections.
Causes and risk factors
Kleefstra syndrome due to a point mutation is caused by a change in the EHMT1 gene, usually arising new in the child and less often inherited from a parent. Risk is mainly genetic, though early support can affect day-to-day challenges and complications.
Genetic influences
Genetics are central to Kleefstra syndrome due to a point mutation, because a change in the EHMT1 gene is the direct cause. The exact variant can slightly affect features, but genetics mainly confirms the diagnosis and helps guide family counseling.
Diagnosis
Kleefstra syndrome due to a point mutation is usually suspected from clinical features and development history, then confirmed with genetic tests. The genetic diagnosis of Kleefstra syndrome identifies a change in the EHMT1 gene.
Treatment and drugs
Treatment for Kleefstra syndrome due to a point mutation focuses on daily needs rather than one single medicine. Many benefit from speech, physical, and occupational therapy, plus tailored support for learning, sleep, seizures, heart problems, or behavior.
Symptoms
Kleefstra syndrome due to a point mutation often shows up early as low muscle tone, delayed development, and slower speech and learning. These features can affect feeding, movement, communication, sleep, and behavior in daily life. Some people also have related health concerns, such as seizures or differences in the heart, kidneys, urinary tract, or genitals. Features vary from person to person, and some are mild while others need ongoing support.
Babies and children often feel floppy and may take longer to hold up the head, sit, crawl, or walk. Low muscle tone can also make feeding, posture, and coordination harder in everyday life. Physical and occupational therapy can help build strength and practical skills.
Learning, problem-solving, and everyday skills often develop more slowly than expected. Many living with Kleefstra syndrome due to a point mutation need extra support with play, dressing, toileting, or school tasks. The level of support needed can range from mild to substantial.
Speech is often very delayed, and some people use only a few words or rely on gestures or communication devices. Understanding may be stronger than spoken language, but this varies. Early communication support can make daily needs and social connection easier.
Many people have autism-like traits, attention problems, anxiety, or frustration when routines change. Social communication can be hard, and some may repeat certain movements or behaviors. These patterns can affect school, transitions, and family routines.
How people usually first notice Kleefstra syndrome due to a point mutation?
For many families, the first signs of Kleefstra syndrome are noticed in infancy or early childhood, when a baby seems unusually floppy because of low muscle tone, feeding is harder than expected, or milestones like sitting, walking, and first words come later than usual. As children grow, doctors may also notice developmental delay, speech that is very limited or absent, and a pattern of facial features that can suggest Kleefstra syndrome, although the exact features and timing can vary from child to child. In some cases, Kleefstra syndrome due to a point mutation is first recognized after genetic testing is ordered to explain global developmental delay, intellectual disability, or related health concerns such as sleep problems, seizures, or congenital heart differences.
Types of Kleefstra syndrome due to a point mutation
No distinct types of Kleefstra syndrome due to a point mutation are widely recognized.
Can I slow down the onset of symptoms?
No. For Kleefstra syndrome caused by a small change in a gene, there is no good evidence that lifestyle changes, diet, supplements, or medicines can meaningfully delay when symptoms begin, because this condition starts during early development, often before birth. What can help is early support and regular medical follow-up: speech, movement, and learning therapies, along with checks for sleep problems, seizures, heart issues, hearing, and vision, may improve day-to-day function and catch treatable problems early, but they do not prevent the condition itself. Research is ongoing, and while early care can make a real difference for many living with Kleefstra syndrome, it cannot guarantee a later start of symptoms.
What genetics can tell you about symptoms
In Kleefstra syndrome caused by a point mutation, changes in the EHMT1 gene are the known genetic cause, but genetics usually cannot predict exactly which symptoms someone will have day to day. Many living with this condition share a core pattern, such as developmental delay, low muscle tone, speech difficulties, and learning problems, yet the type of variant may influence how severe some features are and whether other problems, like seizures, heart differences, or behavior and sleep issues, are also present. Even within the same genetic diagnosis, symptoms can begin at different ages and vary widely from one person to another, so the genetic result gives an important clue about the condition but not a precise forecast.
Causes and risk factors
For most families, the cause is a harmful single-letter change in the EHMT1 gene. In Kleefstra syndrome, this change is usually new in the child, but it can sometimes be inherited from a parent. Genetic testing can sometimes clarify your personal risk. Other genes, overall health, and early-life environment may affect how strongly Kleefstra syndrome shows up, but they do not cause it. Lifestyle does not cause Kleefstra syndrome either, though sleep, nutrition, and supportive care can shape day-to-day health.
What are the most common causes or risk factors?
This form of Kleefstra syndrome is caused by a tiny harmful change in a gene called EHMT1, which is important for early brain and body development. In many living with this condition, the gene change happens for the first time in the child and is not linked to anything a parent did before or during pregnancy. The main known risk factor is family history, because in a small number of families the change can be passed down from a parent or be present only in some of a parent’s egg or sperm cells, even if that parent has no clear symptoms.
Environmental and biological risk factors
Kleefstra syndrome due to a point mutation most often starts with a new DNA change that happens by chance around conception. Doctors often group risks into internal (biological) and external (environmental). For this condition, the main known influences are biological, and the risk of Kleefstra syndrome due to a point mutation in another pregnancy is usually low unless a hidden change is present in some egg or sperm cells.
Most cases start from a new point mutation that appears in the egg, the sperm, or very soon after conception. This usually happens by chance and is not something parents caused.
As fathers get older, sperm cells have had more time to build up new point mutations. This can modestly raise the chance of rare conditions caused by a new single-gene change, although the overall risk stays low.
Rarely, a parent carries the change in a small number of egg or sperm cells while feeling completely well. This can make the condition more likely to happen again in another pregnancy, even when a standard blood test is normal.
No specific environmental exposure has been proven to cause Kleefstra syndrome due to a point mutation. High-dose ionizing radiation can damage DNA in general, but a direct link to this syndrome has not been clearly established.
Genetic risk factors
For families wondering why this happened, Kleefstra syndrome due to a point mutation usually begins with a small DNA spelling change in a gene called EHMT1. That change can disrupt early brain and body development because the gene no longer works as it should. Some risk factors are inherited through our genes, but in this condition the change most often appears for the first time in the child. Knowing the genetic causes of Kleefstra syndrome can help explain recurrence risk for future pregnancies.
EHMT1 change: Kleefstra syndrome due to a point mutation is caused by a harmful change in one copy of the EHMT1 gene. This usually means the body cannot make enough working EHMT1 protein, or the protein does not work properly.
Point mutation type: The change is usually a small spelling error that creates an early stop signal or disrupts how EHMT1 is read. These small changes are different from a larger missing piece of chromosome 9, but they can lead to the same syndrome.
De novo variant: In most families, the EHMT1 change is new in the child, also called de novo, and is not found in either parent. When this happens, the chance of the same condition in another pregnancy is usually low, although it is not zero.
Inherited variant: Sometimes the change is passed down from a parent in an autosomal dominant pattern, which means one altered copy is enough to cause the syndrome. If a parent carries the variant, each pregnancy has a 1 in 2, or 50%, chance of inheriting it.
Parental mosaicism: Rarely, a parent has the EHMT1 change in only some of their cells, a situation called mosaicism. Blood testing may miss this, and it can make recurrence risk higher than expected even when both parents seem unaffected.
Lifestyle risk factors
Kleefstra syndrome due to a point mutation is not caused by lifestyle habits, but daily routines can still influence how symptoms are managed and how complications develop. When people ask about lifestyle risk factors for Kleefstra syndrome, the most useful focus is on habits that affect sleep, mobility, feeding, behavior, communication, and general medical stability. Because this condition often involves developmental delay, low muscle tone, behavioral differences, and sleep problems, supportive lifestyle choices are usually tailored to the person’s abilities and needs.
Irregular sleep schedules or poor sleep habits can worsen daytime behavior, attention, and irritability in Kleefstra syndrome. A consistent bedtime routine and good sleep hygiene may help reduce sleep disruption and improve daytime functioning.
Too little movement can worsen low muscle tone, poor endurance, constipation, and excess weight gain, which are common concerns in Kleefstra syndrome. Regular adapted activity and physiotherapy-based exercise may support mobility, posture, fitness, and comfort.
Unbalanced eating patterns, frequent high-calorie snacks, or inadequate fiber and fluids can increase the risk of obesity and constipation in Kleefstra syndrome. For people with feeding or chewing difficulties, individualized nutrition planning can improve growth, energy, and bowel regularity.
Highly unpredictable routines, overstimulation, or repeated stress can aggravate behavioral outbursts, anxiety, or difficulty with transitions in Kleefstra syndrome. Structured days with clear cues and calm environments often help behavior regulation and participation.
Risk prevention
Kleefstra syndrome due to a point mutation is a genetic condition present from birth, so there is no known way to prevent the syndrome itself. For families and clinicians, prevention usually means lowering the risk of complications, spotting problems early, and supporting development, sleep, feeding, and overall health. Different people need different prevention strategies—there’s no single formula. Early, steady care can make day-to-day life easier and may reduce some of the medical issues linked with Kleefstra syndrome.
If Kleefstra syndrome due to a point mutation has been identified in a child or family member, genetic counseling can clarify recurrence risk for future pregnancies. Testing the parents may show whether the variant happened for the first time or was inherited, which helps guide family planning.
For some families, prenatal testing or preimplantation genetic testing may be options in a future pregnancy when the family's specific variant is known. These steps do not treat Kleefstra syndrome, but they can help with informed reproductive decisions.
Early speech, physical, occupational, and developmental therapy can help prevent avoidable delays from becoming more limiting over time. For many living with Kleefstra syndrome, starting support early can improve communication, movement, and daily skills.
Babies and children with Kleefstra syndrome may have feeding problems, reflux, or poor weight gain, so early feeding assessment can help prevent dehydration and undernutrition. If meals are tiring, coughing happens with feeds, or weight gain is slow, a swallowing and nutrition review is important.
Can you prevent Kleefstra syndrome due to a point mutation?
No, Kleefstra syndrome due to a point mutation usually cannot be prevented, because it is caused by a change in a gene that is typically present from the very start of development and is not caused by anything parents did or did not do. If there is a known family history or a parent is known to carry the gene change, genetic counseling may help explain the chances in a future pregnancy and discuss testing options, but it cannot guarantee prevention.
Transmission
Kleefstra syndrome due to a point mutation is not infectious, so it cannot spread from one person to another through coughing, touching, kissing, sex, or sharing food. Instead, how Kleefstra syndrome is inherited depends on a change in a single gene: most people with Kleefstra syndrome have a new genetic change that happened for the first time in them, so neither parent has the condition.
Less often, the gene change is passed down from a parent in an autosomal dominant pattern, which means one altered copy of the gene can be enough to cause Kleefstra syndrome. If a parent carries that change, each pregnancy has a 50% chance of inheriting it, so genetic counseling can help families understand the genetic transmission of Kleefstra syndrome.
When to test your genes
Consider genetic testing when a child has unexplained developmental delay, low muscle tone, speech delay, autism features, seizures, or heart or kidney differences along with suggestive facial features. For Kleefstra syndrome, testing is mainly done to confirm the diagnosis and guide care, rather than for routine early screening in healthy people.
Diagnosis
Kleefstra syndrome due to a point mutation is usually diagnosed by noticing a pattern of developmental and physical features, then confirming the cause with genetic testing. Many living with Kleefstra syndrome come to medical attention because of delayed speech, low muscle tone, learning difficulties, or a combination of these signs. The genetic diagnosis of Kleefstra syndrome helps confirm the condition and can guide care, support, and family counseling.
Doctors look at the overall pattern of signs, such as developmental delay, low muscle tone, distinctive facial features, and behavior or sleep concerns. No single feature proves the diagnosis, but the combination can strongly suggest Kleefstra syndrome.
A detailed family and health history can help show when symptoms began and whether similar findings have appeared in relatives. This also helps doctors consider other genetic conditions that can look similar.
Specialists often assess speech, learning, movement, and daily skills to build a full picture of how the condition affects the child. These findings support the diagnosis and help plan therapies and school services.
A DNA test is used to look for a change in the EHMT1 gene, which confirms Kleefstra syndrome due to a point mutation. This is the main test used for diagnosis of Kleefstra syndrome when the condition is suspected.
How is Kleefstra syndrome due to a point mutation diagnosed?
Kleefstra syndrome is usually suspected when a child has a pattern of developmental delay, very limited speech, low muscle tone, and certain physical features seen during a medical exam. Doctors usually confirm it with genetic testing, which looks for a small change in the EHMT1 gene; this small change is what is meant by a point mutation. After the diagnosis is made, other tests such as heart, hearing, sleep, or brain checks may be done to look for related health problems, but these tests do not by themselves diagnose the condition.
Stages of Kleefstra syndrome due to a point mutation
Kleefstra syndrome due to a point mutation does not have defined progression stages. This is because it is a genetic condition that is usually recognized by a pattern of developmental and health features, rather than by a steady step-by-step worsening over time. Often the process begins when you notice changes in daily life, and the early symptoms of Kleefstra syndrome due to a point mutation may include low muscle tone, delays in sitting or walking, speech delay, learning problems, and sometimes seizures or sleep difficulties. Doctors usually start with a conversation about development, behavior, and medical history, then use an exam and genetic testing to confirm the diagnosis and monitor related issues over time.
Outlook and prognosis
The outlook for kleefstra syndrome due to a point mutation is quite variable, but most affected people have lifelong developmental and intellectual disabilities that require ongoing support. Motor, speech, and learning progress usually continues over time, although many individuals remain significantly delayed and need special education, speech therapy, and assistance with daily living. Prognosis is also influenced by associated medical problems such as epilepsy, congenital heart defects, sleep disturbances, feeding issues, behavioral or psychiatric symptoms, and recurrent infections, which can increase illness burden if not recognized and treated. Life expectancy is not well defined because the condition is rare, but many people survive into adolescence and adulthood, especially with good multidisciplinary care and monitoring for complications. Mortality is not thought to be uniformly high from the genetic diagnosis itself; when deaths occur, they are more likely related to severe associated complications rather than the point mutation alone. Regular follow-up with neurology, cardiology, developmental specialists, and other relevant clinicians can improve quality of life and help reduce preventable risks.
Long-term effects
Many living with Kleefstra syndrome due to a point mutation need lifelong support because the condition can affect learning, communication, movement, behavior, and general health in different ways. Long-term effects vary widely, even among people with changes in the same gene, so some features stay fairly stable while others become more noticeable with age. In childhood, daily life may center on developmental delays and low muscle tone, while in adolescence and adulthood, sleep, mood, seizures, and organ-related health issues can play a larger role. Thinking about the long-term effects helps families and clinicians plan for changing needs over time.
Intellectual disability is usually a long-term feature of Kleefstra syndrome due to a point mutation, and many people continue to need help with school, daily tasks, and independent living as they grow older. Speech and language are often more affected than social interest, so someone may understand more than they can clearly say.
Many people with Kleefstra syndrome have very limited spoken language or remain minimally verbal over time. This can affect learning, relationships, and everyday choices, especially when needs or discomfort are hard to express.
Low muscle tone often starts early and can continue into later childhood or adult life, affecting posture, stamina, and coordination. For many, this can mean delayed walking, a tiring gait, or trouble with fine motor tasks like buttons, utensils, and writing.
Long-term effects can involve autism-related traits, anxiety, attention difficulties, or periods of withdrawal and reduced engagement. In some teenagers and adults, behavior or mood changes may become more prominent than the early symptoms of Kleefstra syndrome that first led to evaluation.
How is it to live with Kleefstra syndrome due to a point mutation?
Living with Kleefstra syndrome can mean a child or adult needs ongoing support with communication, learning, and daily routines, and many also live with low muscle tone, sleep problems, or behavior differences that can make ordinary days feel less predictable. Some people with Kleefstra syndrome are affectionate and social, but they may still have trouble expressing needs, handling change, or managing sensory stress, so school, therapy, and home life often work best with structure, repetition, and patience. For families and other close supporters, this can bring deep connection as well as extra caregiving demands, appointments, and advocacy, which is why steady support from therapists, teachers, relatives, and community services can make such a meaningful difference.
Treatment and drugs
Treatment for Kleefstra syndrome due to a point mutation focuses on the problems it causes day to day, because there is no medicine yet that fixes the underlying genetic change. Treatment often looks different for each person, but many living with Kleefstra syndrome benefit from a mix of speech, physical, and occupational therapy, along with special education and behavioral support. Doctors may also treat related issues such as seizures, sleep problems, reflux, constipation, anxiety, or heart concerns with standard medicines and regular follow-up, depending on what is present. Early support can matter a lot, since the early symptoms of Kleefstra syndrome often involve delayed development, low muscle tone, and communication difficulties that respond best to ongoing care. Support from family or friends can make daily treatment easier, and care is usually coordinated by a pediatrician or specialist team.
Can you cure Kleefstra syndrome due to a point mutation?
No, there is currently no cure for Kleefstra syndrome caused by a small change in a gene. Treatment focuses on helping with day-to-day needs, such as speech, learning, behavior, movement, sleep, seizures, and other health problems, and many living with it benefit from therapies, special education support, and regular care from a team of doctors. These treatments do not remove the genetic change, but they can improve comfort, skills, and quality of life.
Non-drug treatment
Daily life with Kleefstra syndrome due to a point mutation often involves delays in communication, learning, movement, and self-care, so non-drug support usually starts early and builds over time. Many living with Kleefstra syndrome benefit from a mix of therapies at home, in school, and through specialist services, tailored to their strengths and needs. Supportive therapies can improve comfort, participation, and independence, even though progress may be gradual. Not every approach works the same way, and plans often change as a child grows.
Speech and language therapy can help with understanding, speaking, gestures, and other ways to communicate. For children who speak very little, tools such as picture boards or speech devices can make daily needs and feelings easier to express. Early support for communication in Kleefstra syndrome can also reduce frustration during meals, play, and school.
Physical therapy helps build strength, balance, posture, and coordination, which can be affected by low muscle tone. This may make everyday tasks easier, such as climbing stairs, getting up from the floor, or keeping up on the playground. Stretching and guided exercises can also support joint mobility and safer movement.
Occupational therapy focuses on daily skills like dressing, feeding, handwriting, play, and using the hands. Many people with Kleefstra syndrome also need help with sensory challenges, such as becoming overwhelmed by noise, textures, or busy spaces. Some strategies can slip naturally into your routine, like using visual steps for toothbrushing or calmer setups for meals.
Feeding therapy can help with chewing, swallowing, food textures, and mealtime routines when eating is difficult. This is especially useful if the early symptoms of Kleefstra syndrome include poor feeding, long meals, or trouble moving from purees to more solid foods. Dietitians and speech or occupational therapists often work together when growth or nutrition is a concern.
Your genes may have an impact on how drugs work for you
For people living with Kleefstra syndrome caused by a small change in one gene, that gene change itself is not known to clearly predict how most medicines will work or what side effects they may cause. In day-to-day care, medicines are usually chosen based on the person’s symptoms, such as seizures, sleep problems, behavior changes, or stomach issues, and doctors often adjust treatment by watching closely to see what helps and what causes problems. Even so, some people may have other inherited differences that affect how their body breaks down certain medicines, so if a drug is not helping as expected or is causing unusual side effects, the care team may consider more personalized testing.
Pharmacological treatments
There is no single medicine that treats Kleefstra syndrome due to a point mutation itself, so drug treatment is usually aimed at specific symptoms and day-to-day challenges. Many living with Kleefstra syndrome may be prescribed medicines for seizures, sleep problems, behavior or attention symptoms, reflux, constipation, or mood concerns, depending on what affects them most. Not everyone responds to the same medication in the same way, and care is usually individualized with a pediatrician, neurologist, psychiatrist, or other specialist. In practice, treatment is often guided by the early symptoms of Kleefstra syndrome that are causing the most difficulty.
If seizures are present, doctors may use anti-seizure medicines such as levetiracetam, valproic acid, lamotrigine, or clobazam. The choice depends on seizure type, age, other health issues, and side effects.
Sleep problems may be treated with melatonin, and sometimes clonidine or trazodone is used when falling asleep or staying asleep is very difficult. Some medicines work quickly, while others may need careful dose adjustment and monitoring for daytime sleepiness.
For attention, impulsivity, or marked hyperactivity, doctors may prescribe stimulants such as methylphenidate or amphetamine-based medicines, or nonstimulants such as guanfacine, clonidine, or atomoxetine. These drugs can help some children focus better or settle enough to take part in school and therapy.
Anxiety, low mood, or repetitive distress may sometimes be treated with selective serotonin reuptake inhibitors such as sertraline, fluoxetine, or escitalopram. These medicines are usually started low and increased slowly because sensitivity to side effects can vary.
Genetic influences
For families trying to understand why a child has Kleefstra syndrome due to a point mutation, the main cause is a change in one copy of the EHMT1 gene. Genes are the instructions your body uses to grow and function, and EHMT1 helps control how other genes are turned on and off during early development, especially in the brain. In this form of Kleefstra syndrome, a point mutation is a small change within EHMT1 rather than a larger missing piece of chromosome 9, but either type of change can reduce how well the gene works. The condition follows an autosomal dominant pattern, which means one altered copy is enough to cause symptoms, although most cases happen for the first time in the child and are not inherited from a parent. Less often, the gene change is inherited from a parent who also has Kleefstra syndrome or from a parent with mosaicism, where the change is present in only some of their cells. Genetic testing can confirm the diagnosis and help families understand how Kleefstra syndrome is inherited, the chance of it happening again, and what it may mean for future pregnancies.
Is Kleefstra syndrome due to a point mutation genetic?
Genetics are central to Kleefstra syndrome due to a point mutation, because a change in the EHMT1 gene is the direct cause. The exact variant can slightly affect features, but genetics mainly confirms the diagnosis and helps guide family counseling.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a common and normal part of being human. Most do not directly affect health and simply reflect natural differences among people. For many genes, having a variant associated with a condition suggests a possible link, not a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-understood variant in a particular gene is enough to establish the diagnosis.
Pharmacogenetics—how genetics influence drug effects
For families, treatment usually focuses on the problems that most affect daily life, such as seizures, sleep trouble, reflux, constipation, anxiety, or challenging behaviors. In Kleefstra syndrome due to a point mutation, the genetic result mainly helps by confirming the diagnosis and alerting the care team to related health issues that may need screening or treatment early. There is not yet a medicine that corrects the underlying gene change itself, so drugs are usually chosen to match each symptom rather than to target the mutation. Not every difference in response is genetic, but the gene finding can still shape care by guiding follow-up, therapy referrals, and checks for problems such as heart or kidney differences in some people. Many living with Kleefstra syndrome due to a point mutation may use medicines that are also used in other children or adults for epilepsy, sleep, mood, or attention symptoms, with careful dose changes because benefits and side effects can vary from one person to another. If several medications do not seem to help or cause unusual side effects, doctors may sometimes consider separate pharmacogenetic testing, but that is different from the test used to diagnose Kleefstra syndrome.
Interactions with other conditions
For many living with Kleefstra syndrome due to a point mutation, health concerns do not happen one at a time, and that can shape daily care in a big way. Seizures, sleep problems, reflux, constipation, and repeated ear or airway infections can overlap, so a rough night’s sleep or a chest infection may leave someone more tired, less focused, or more prone to behavior changes the next day. Heart defects and kidney or urinary tract problems are also seen in some people with Kleefstra syndrome, which is why doctors often look beyond the nervous system when checking overall health. Doctors call it a “comorbidity” when two conditions occur together. Many children and adults with Kleefstra syndrome also have autism traits, low muscle tone, or obesity, and these can affect mobility, communication, feeding, and breathing during sleep. Because the pattern can vary so much, care is often best when neurology, developmental, heart, and primary care teams share information and watch for early symptoms of related health problems.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Kleefstra syndrome due to a point mutation?
Other conditions that can look similar to Kleefstra syndrome include Smith-Magenis syndrome, Pitt-Hopkins syndrome, Angelman syndrome, and some forms of autism or broader developmental delay, because all can involve delayed speech, low muscle tone, learning problems, and behavior or sleep issues. Doctors usually tell them apart by looking at the full pattern of features and confirming the cause with genetic testing.
History
Families often begin the story of Kleefstra syndrome long before there is a name for it. A baby may seem very floppy, feeding can be harder than expected, and later on parents may notice delays with sitting, walking, or speech. In many living with Kleefstra syndrome, these early differences led to years of appointments and uncertainty before doctors could connect the pattern.
The condition was recognized gradually as doctors compared children who shared a similar mix of developmental delay, low muscle tone, learning difficulties, and distinctive physical features. Initially understood only through symptoms, later research showed that these findings were part of the same syndrome rather than unrelated problems. As medical genetics improved in the late 20th and early 21st centuries, specialists became better at identifying children and adults with Kleefstra syndrome, including people whose signs were milder or had been labeled in other ways earlier in life.
That change mattered in everyday care. Instead of focusing on one symptom at a time, such as delayed speech or sleep trouble, clinicians could start to see the broader picture and guide families toward developmental support, heart checks when needed, and behavior or learning help. Over time, the way the condition has been understood has changed, but the goal has stayed the same: helping people with Kleefstra syndrome get answers, practical care, and support that fits their needs.
In more recent years, researchers confirmed that Kleefstra syndrome has a genetic cause, which helped explain why the condition appears so early in life and why the features tend to occur together. This also improved testing, making it easier to diagnose people who have the early symptoms of Kleefstra syndrome without years of guesswork. Even so, the history of Kleefstra syndrome is still being written, as doctors continue learning why symptoms can vary so much from one person to another.